Patients with high PROK1 expression had significantly higher immunity, stromal, and ESTIMATE (Estimation of stromal and immune cells in malignant tumor tissues using expression data) scores, suggesting that PROK1 may modulate the tumor immune microenvironment to exert a cancer-inhibitory effect (Fig. 10G). The gene discussed is PROK1; the disease is cancer.